UI Hospitals and Clinics
A Study of ALT-801 in Patients with Relapsed or Refractory Multiple Myeloma
Participants in this research study have been diagnosed with a type of multiple myeloma that has grown or spread and cannot be cured by surgery, radiation or any other conventional therapies. The purpose of this research study is to identify the side effects of the study drug, ALT-801, in patients with multiple myeloma, and to find out how safe it is, and how well it is tolerated. Investigators also wish to find out if the study drug can slow the progression of the disease and/or reduce the size of the tumors.
Karen Parrott, 319-353-6347
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.